Human genomics of the humoral immune response against polyomaviruses

Hodel, F.; Chong, A. Y.; Scepanovic, P.; Xu, Z. M.; Naret, O.; Thorball, C. W.; Rüeger, S.; Marques-Vidal, P.; Vollenweider, P.; Begemann, M.; Ehrenreich, H.; Brenner, N.; Bender, N.; Waterboer, T.; Mentzer, A. J.; Hill, A. V. S.; Hammer, C.; Fellay, J.

doi:10.1093/ve/veab058

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Human genomics of the humoral immune response against polyomaviruses

MPS-Authors

/persons/resource/persons182563

Begemann, M.
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182138

Ehrenreich, H.
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

3374484.pdf
(Publisher version), 934KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Hodel, F., Chong, A. Y., Scepanovic, P., Xu, Z. M., Naret, O., Thorball, C. W., et al. (2021). Human genomics of the humoral immune response against polyomaviruses. Virus Evolution, 7(2): veab058. doi:10.1093/ve/veab058.

Cite as: https://hdl.handle.net/21.11116/0000-000A-2BC7-6

Abstract

Human polyomaviruses are widespread in humans and can cause severe disease in immunocompromised individuals. To identify human genetic determinants of the humoral immune response against polyomaviruses, we performed genome-wide association studies and meta-analyses of qualitative and quantitative immunoglobulin G responses against BK polyomavirus (BKPyV), JC polyomavirus (JCPyV), Merkel cellpolyomavirus (MCPyV), WU polyomavirus (WUPyV), and human polyomavirus 6 (HPyV6) in 15,660 individuals of European ancestry from three independent studies. We observed significant associations for all tested viruses: JCPyV, HPyV6, and MCPyV associated with human leukocyte antigen class II variation, BKPyV and JCPyV with variants in FUT2, responsible for secretor status, MCPyV with variants in STING1, involved in interferon induction, and WUPyV with a functional variant in MUC1, previously associated with risk for gastric cancer. These results provide insights into the genetic control of a family of very prevalent human viruses, highlighting genes and pathways that play a modulating role in human humoral immunity.